Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction

Journal of Cardiac Failure

Volumn 17, Issue 1, 2011, Pages 31-38

  Carrasco Sánchez, Francisco Javier ^a   Galisteo Almeda, Luis ^a   Páez Rubio, Inmaculada ^a   Martínez Marcos, Francisco Javier ^a   Camacho Vázquez, Crescencio ^a   Ruiz Frutos, Carlos ^b   Pujol De La Llave, Emilio ^a  

^a HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^b UNIVERSITY OF HUELVA   (Spain)

Author keywords

creatinine; Cystatin C; heart failure; preserved ejection fraction; renal dysfunction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NATRIURETIC PEPTIDE RECEPTOR A; UREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYSTATIN C; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PATIENT READMISSION; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 78650694898     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2010.07.248     Document Type: Article

References (32)

1. J.J. McMurray, and S. Stewart Heart failure: epidemiology, etiology and prognosis of heart failure Heart 83 2000 596 602
2. C. Tribouilloy, D. Rusinaru, H. Mahjoub, V. Souliere, F. Levy, and M. Peltier Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study Eur Heart J 29 2008 339 347
3. M.T. Maeder, and D.M. Kaye Heart failure with normal left ventricular ejection fraction J Am Coll Cardiol 53 2009 905 918
4. G.L. Smith, J.H. Lichtman, M.B. Bracken, M.G. Shlipak, C.O. Phillips, and P. DiCapua Renal impairment and outcomes in heart failure: systematic review and meta-analysis J Am Coll Cardiol 47 2006 1987 1996
5. R. Hojs, S. Bevc, R. Ekart, M. Gorenjak, and L. Puklavec Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease Ren Fail 30 2008 181 186
6. R. Hojs, S. Bevc, R. Ekart, M. Gorenjak, and L. Puklavec Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease Clin Nephrol 70 2008 10 17
7. T. Keller, C.M. Messow, E. Lubos, V. Nicaud, P.S. Wild, and H.J. Rupprecht Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study Eur Heart J 30 2009 314 320
8. E. Ichimoto, K. Jo, Y. Kobayashi, T. Inoue, Y. Nakamura, and N. Kuroda Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction Circ J 73 2009 1669 1673
9. N. Taglieri, D.J. Fernandez-Berges, W. Koenig, L. Consuegra-Sanchez, J.M. Fernandez, and N.R. Robles Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with nonST elevation acute coronary syndrome Atherosclerosis 209 2010 300 305
10. M.G. Shlipak, R. Katz, L.F. Fried, N.S. Jenny, C.O. Stehman-Breen, and A.B. Newman Cystatin-C and mortality in elderly persons with heart failure J Am Coll Cardiol 45 2005 268 271
11. J. Lassus, V.P. Harjola, R. Sund, K. Siirila-Waris, J. Melin, and K. Peuhkurinen Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Eur Heart J 28 2007 1841 1847
12. L. Djousse, T. Kurth, and J.M. Gaziano Cystatin C and risk of heart failure in the Physicians' Health Study (PHS) Am Heart J 155 2008 82 86
13. U. Alehagen, U. Dahlstrom, and T.L. Lindahl Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care Eur J Heart 11 2009 354 360
14. H. Naruse, J. Ishii, T. Kawai, K. Hattori, M. Ishikawa, and M. Okumura Cystatin C in acute heart failure without advanced renal impairment Am J Med 122 2009 566 573
15. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 2008 2388 2442
16. K.M. Chinnaiyan, D. Alexander, M. Maddens, and P.A. McCullough Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure Am Heart J 153 2007 189 200
17. M. Fricker, P. Wiesli, M. Brandle, B. Schwegler, and C. Schmid Impact of thyroid dysfunction on serum cystatin C Kidney Int 63 2003 1944 1947
18. L. Risch, R. Herklotz, A. Blumberg, and A.R. Huber Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients Clin Chem 47 2001 2055 2059
19. E.J. Erlandsen, E. Randers, and J.H. Kristensen Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System Scand J Clin Lab Invest 59 1999 1 8
20. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
21. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S46 S75
22. M.J. Pencina, R.B. d'Agostino Sr., R.B. d'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
23. A. Larsson, J. Malm, A. Grubb, and L.O. Hansson Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L Scand J Clin Lab Invest 64 2004 25 30
24. W.J. Paulus, C. Tschope, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, and F.E. Rademakers How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550
25. J.H. Ix, M.G. Shlipak, G.M. Chertow, S. Ali, N.B. Schiller, M.A. Whooley, and C. Cystatin left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study J Card Fail 12 2006 601 607
26. A. Moran, R. Katz, N.L. Smith, L.F. Fried, M.J. Sarnak, and S.L. Seliger Cystatin C concentration as a predictor of systolic and diastolic heart failure J Card Fail 14 2008 19 26
27. R.S. Bhatia, J.V. Tu, D.S. Lee, P.C. Austin, J. Fang, and A. Haouzi Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269 (Pubitemid 44088349)
28. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
29. F.J. Hoek, F.A. Kemperman, and R.T. Krediet A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate Nephrol Dial Transplant 18 2003 2024 2031
30. G.C. Fonarow, K.F. Adams Jr., W.T. Abraham, C.W. Yancy, and W.J. Boscardin Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 2005 572 580
31. C.Y. Campbell, W. Clarke, H. Park, N. Haq, B.B. Barone, and D.J. Brotman Usefulness of cystatin C and prognosis following admission for acute heart failure Am J Cardiol 104 2009 389 392
32. S. Manzano-Fernandez, M. Boronat-Garcia, M.D. Albaladejo-Oton, P. Pastor, I.P. Garrido, and F.J. Pastor-Perez Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic peptide and cardiac troponin T in patients with acute heart failure Am J Cardiol 103 2009 1753 1759